Rankings
▼
Calendar
COLL Q1 2017 Earnings — Collegium Pharmaceutical, Inc. Revenue & Financial Results | Market Cap Arena
COLL
Collegium Pharmaceutical, Inc.
$1B
Q1 2017 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$2M
Gross Profit
$2M
82.9% margin
Operating Income
-$23M
-1067.0% margin
Net Income
-$23M
-1062.5% margin
EPS (Diluted)
$-0.79
QoQ Revenue Growth
+66.7%
Cash Flow
Operating Cash Flow
-$24M
Free Cash Flow
-$24M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$140M
Total Liabilities
$25M
Stockholders' Equity
$114M
Cash & Equivalents
$130M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2M
$0
—
Gross Profit
$2M
$0
—
Operating Income
-$23M
-$16M
-48.7%
Net Income
-$23M
-$16M
-47.4%
← FY 2017
All Quarters
Q2 2017 →